Estimating treatment effects with treatment switching via semicompeting risks models: an application to a colorectal cancer study
DOI10.1093/BIOMET/ASR062zbMath1437.62669OpenAlexW1985867206WikidataQ36142974 ScholiaQ36142974MaRDI QIDQ3224224
Amgen Research Group, Donglin Zeng, Qingxia Chen, Joseph G. Ibrahim, Ming-Hui Chen
Publication date: 29 March 2012
Published in: Biometrika (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc3412606
noncomplianceexpectation-maximization algorithmmaximum likelihood estimatetransition modelpartial switchingpanitumumab
Computational methods for problems pertaining to statistics (62-08) Asymptotic properties of nonparametric inference (62G20) Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50) Estimation in survival analysis and censored data (62N02)
Related Items (9)
This page was built for publication: Estimating treatment effects with treatment switching via semicompeting risks models: an application to a colorectal cancer study